XML 64 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule Of Shares Of Common Stock Reserved For Future Issuance
The Company has the following common stock reserved for future issuance as of December 31, 2024:
December 31, 2024
Outstanding options16,321,014 
Outstanding RSUs12,331,745 
Shares reserved under 2021 Plan4,423,347 
Total33,076,106 
Share-Based Payment Arrangement, Activity
A summary of the Company's stock option activity with respect to options granted under the Plans is as follows:

Number of Options
Weighted
Average exercise price
Weighted remaining contractual term (years)Aggregate
Intrinsic
Value








Outstanding as of January 1, 2024

22,933,058$4.99 6.29$5,378 


Granted

— — 
Exercised

(1,796,434)$0.99 $1,449 
Forfeited

(4,815,610)$12.26 
Outstanding as of December 31, 2024

16,321,014$3.29 4.34$5,212 


Exercisable options at end of the year

16,302,264$3.29 4.33$5,212 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity
The following table summarizes the RSU activity for the year ended December 31, 2024:


RSUs
Outstanding

Weighted Average
Grant Date Fair
Value per Share
Outstanding as of December 31, 2023

11,199,265$2.24
RSUs granted

13,616,089$1.45
RSUs vested

(9,910,366)$2.09
RSUs forfeited

(2,573,243)$1.91
Unvested and Outstanding as of December 31, 2024

12,331,745$1.56
Share-Based Payment Arrangement, Cost by Plan
The stock-based compensation expense by line item in the accompanying consolidated statement of operations is summarized as follows:

 Year Ended December 31,
202420232022
Cost of revenue$1,002 $1,128 $1,376 
Research and development4,775 4,734 4,268 
Sales and marketing2,701 3,187 3,711 
General and administrative17,786 20,931 14,290 
Total expenses$26,264 $29,980 $23,645